| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.2 | 8e-09 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |